Pope Francis' friends around Rome pray for him as he fights pneumonia
Francis has popped in a few times since becoming pope in 2013 to get new lenses for his glasses, arriving in a simple Ford or Fiat with minimal security detail and waving to well-wishers as he came and went.
Advertisement
The Argentine pope also has his favorite ice cream flavors, and a shop near his Vatican hotel has catered for years to his sweet tooth.
When Argentine ice cream maker Sebastian Padrón opened his gelato laboratory around the corner from the Santa Marta hotel, his dulce de leche ice cream, a typical Argentine caramel dessert, became the pope's favorite.
'He called me on the phone after COVID to invite me,' Padròn told The Associated Press. 'He wanted to meet me since he had been eating our ice cream for a few years. We went with my family, we talked to him for a long time. A very nice meeting, very friendly, very simple, as if we were neighbors and as if we had known each other our whole lives.'
Padròn added: 'After we came to know of the hospitalization we sent him our greetings, and as he always says, we must pray for him,' he said.
A Vatican-area tailor also was following news of Francis' hospitalization.
'We are all saddened and we all pray for the recovery of the pope,' said Raniero Mancinelli, who sold the modest pectoral cross that Francis has been wearing for the past few decades.
Before Francis' papacy, Mancinelli sold lavish crosses set with gemstones to cardinals and bishops. But afterward, the clerical style shifted to simpler crosses made of silver, Mancinelli said.
Advertisement
They are similar to the one that a bishop friend purchased in 1998 and later gave to the future pope, who at the time was archbishop of Buenos Aires. According to Mancinelli, the current cross that the pope still wears was bought in his shop.
'Francis immediately went on a much simpler and essential style,' he explained as he cut the fabric for a bishop's garment in his historic workshop, steps away from the Vatican.
When he became pope in 2013, Francis decided not to live in the lavish, baroque papal apartments of the Apostolic Palace overlooking St. Peter's Square, but to stay in an austere room at the Santa Marta hotel inside Vatican City.
He has lamented that he can't walk around freely as he did when he lived in Buenos Aires, when he was known for taking public transportation.
As an archbishop, Francis came to Rome frequently on periodic visits to the Vatican and frequented his favorite shops, including
In 2022, when he went to bless the newly renovated shop and visit its owners, a Vatican reporter happened to be nearby and filmed him exiting. Francis later reached out and mused about the attention he draws during his local outings.
'I won't deny that it was (bad luck) that after taking all the precautions, there was a journalist waiting,' Francis later
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
12 hours ago
FDA expands warning label for COVID-19 vaccines
The Food and Drug Administration finalized the expansion of heart risk warning labels on Moderna and Pfizer's mRNA COVID-19 vaccines. Dr. Alok Patel has more medical news to share.
Hamilton Spectator
15 hours ago
- Hamilton Spectator
Alberta strikes deal to off-load remaining batch of controversial children's medicine
EDMONTON - The Alberta government has reached a deal to off-load what remains of its controversial stockpile of unused children's pain and fever medicine. Kristi Bland, with Alberta Health Services, says they are donating the medicine to the charity group Health Partners International of Canada. Bland says shipments have begun and more are expected in the coming months. Jackie Cousins, president of Health Partners, says they work with partners to ship medicine where it is needed, and confirms some of the Alberta medicine will go to war-torn Ukraine. The medication has proven to be problematic for Premier Danielle Smith's government after it struck a deal for the medicine three years ago to fill a gap during the COVID-19 pandemic. Alberta paid $70 million to a private provider for the medicine but has since sat on 1.4 million bottles after front-line health staff reported problems with it, including how the medicine's thicker consistency risked clogging feeding tubes. This report by The Canadian Press was first published June 27, 2025. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
Yahoo
15 hours ago
- Yahoo
As new variant spreads, what's the latest COVID-19 vaccine guidance? It's complicated.
As a new COVID-19 variant takes over in the U.S., guidance surrounding vaccines has become increasingly confusing. Changes in vaccination guidelines, ever-evolving variants and strains, along with threats to health insurance, have sent average Americans looking for the latest recommendations as members of the federal government often conflict with independent medical agencies and healthcare professionals. In the two weeks leading up to June 21, the Centers for Disease Control and Prevention (CDC) reported just shy of 14,500 positive COVID tests, and while hospitalizations and deaths are fortunately down significantly since the pandemic's peak, vulnerable people are still grappling with limiting their risk amid changing practices. Having trouble keeping track of variants and vaccines? Here's what we know. NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent right now, Subhash Verma, microbiology and immunology professor at the University of Nevada, Reno, previously told USA TODAY in May. Verma previously stated that NB.1.8.1 may be transferred more easily than LP.8.1. Additionally, he noted that NB.1.8.1 can evade antibodies created by vaccines or past infections more easily than LP.8.1. In early April, NB.1.8.1 accounted for 0% of COVID cases in the U.S. In the two weeks ending June 21, it accounted for the majority of cases at 43%, according to the CDC. The variant has similar symptoms to other strains, including fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion or a runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting. One of its more unique features is "razor blade throat," reported by patients as an exceptionally sore throat. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. said on May 27 that the COVID-19 vaccine would no longer be included in the CDC's recommended immunization schedule for healthy children and pregnant women, a move that broke with previous expert guidance and bypassed the normal scientific review process. Under the changes, the only people who will be recommended for COVID-19 vaccines are those over 65 and people with existing health problems. This could make it harder for others who want the COVID-19 vaccine to get it, including health care workers and healthy people under 65 with a vulnerable family member or those who want to reduce their short-term risk of infection. The American College of Obstetricians and Gynecologists (ACOG) and American Academy of Pediatrics (AAP), among other organizations, issued statements condemning the change, with the ACOG saying it was "...concerned about and extremely disappointed by the announcement that HHS will no longer recommend COVID-19 vaccination during pregnancy." "It is very clear that COVID-19 infection during pregnancy can be catastrophic and lead to major disability, and it can cause devastating consequences for families. The COVID-19 vaccine is safe during pregnancy, and vaccination can protect our patients and their infants after birth," President Steven J. Fleischman said in a statement. Insurance coverage typically follows federal recommendations, so anyone who is healthy and under 65 is likely to have to pay out of pocket to get the shot, which runs about $200, if they can get it. It's not clear what insurance companies will do about the new recommendations. The American Medical Association (AMA) and American Academy of Pediatrics (AAP), in partnership with other professional medical organizations, broke from RFK and HHS after this announcement, sharing plans to develop their own guidelines independent of the government organization. In an open letter signed by 80 medical organizations across the country and published on June 25, the AMA called for physicians, healthcare networks and insurance companies to continue supporting "evidence-based immunizations to help prevent severe disease and protect public health." "Vaccines for influenza, RSV, and COVID-19 remain among the best tools to protect the public against these illnesses and their potentially serious complications—and physicians are among the most trusted voices to recommend them. We come together as physicians from every corner of medicine to reaffirm our commitment to these lifesaving vaccines," the letter said. "Recent changes to federal immunization review processes raised concerns across the medical and public health community. In this moment of uncertainty, physicians must align around clear, evidence-based guidance for patients." The AAP likewise said in a June 26 statement that it will "continue to publish its own evidence-based recommendations and schedules." AAP President Susan J. Kressly said the creation of federal immunization policy is 'no longer a credible process," adding, "...we're not stepping back, we're stepping up. The AAP will continue to publish our own immunization schedule just as we always have, developed by experts, guided by science, trusted by pediatricians and families across the country.' These latest independent guidelines have yet to be released. Meanwhile, the new Advisory Committee on Immunization Practices (ACIP) gathered for the first time on June 25 in a meeting that drew criticism from some experts. RFK fired all 17 original members of the committee on June 9, replacing them with members that critics have called unqualified. Some of the members, like Kennedy, have a history of anti-vaccine advocacy, prompting backlash that had doctors and organizations calling for a delay in the meeting. Anti-vaccine sentiments were repeated by ACIP Chair Martin Kulldorf at the meeting, who said the panel will be "investigating" MMR and childhood vaccines. The CDC panel also reviewed data about COVID-19 vaccines, questioning their safety and effectiveness. They also raised questions about the study design, methodologies and surveillance monitoring systems behind the data, which Dr. Pamela Rockwell, clinical professor of family medicine at the University of Michigan Medical School, addressed as a standard of medical research. "Our efforts, through a very robust system of checks and balances, are to create vaccines and vaccination programs that result in the most benefit with the least harm," said Dr. Gretchen LaSalle, a family physician in Spokane, Washington, who represented the American Academy of Family Physicians. Despite this, the committee didn't vote on COVID-19 vaccine recommendations for the fall and isn't expected to reconvene until 'September/October,' according to the CDC website. ACIP commitee: Inside the unusual, RFK-appointed panel that's deciding on childhood vaccines The FDA likewise announced updated requirements for mRNA COVID-19 vaccine warning labels on June 25, which apply to Comirnaty by Pfizer Inc. and Spikevax by ModernaTX Inc. Prescribing information will now include warnings of the connection between the vaccines and a rare side effect that causes inflammation of the heart muscle and lining. The new warning label discloses the risk of myocarditis, which appeared in 8 cases per 1 million people who got the 2023-2024 COVID shots between the ages of 6 months and 64 years old, mostly commonly among males aged 12 to 24. The previous label, which also disclosed the risk, said the problem mostly occurred in minors aged 12-17. Despite the back-and-forth in the U.S., the World Health Organization (WHO) has kept its recommendation consistent. Currently approved COVID-19 vaccines are expected to remain effective against the NB.1.8.1 variant, it said. In a webpage dated Jan. 7, the CDC advised that everyone over the age of six months get the 2024-2025 COVID-19 vaccine, specifically the 2024-2025 Moderna COVID-19 Vaccine. The page has since been updated with a banner, reading "COVID-19 vaccine recommendations have recently been updated for some populations. This page will be updated to align with the updated immunization schedule." The original recommendations align with the WHO's current guidelines. WHO, AMA, AAP and existing standards recommend that people who have never received a COVID-19 vaccine, are age 65 and older, are immunocompromised, live at a long-term care facility, are pregnant, breastfeeding, trying to get pregnant, and/or want to avoid getting long COVID, should get the vaccine, especially. Contributing: Greta Cross, Adrianna Rodriguez, USA TODAY This article originally appeared on USA TODAY: What are the latest COVID vaccine guidelines for this summer?
